Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research.

导出 OA

翻译打印收藏纠错

第一作者： Nicola,Silvestris

第一单位： Medical Oncology Unit and Scientific Directorate, Cancer Institute "Giovanni Paolo II", Viale Orazio Flacco, 65, 70124, Bari, Italy. n.silvestris@oncologico.bari.it.

作者： Nicola,Silvestris ^[1] ; Gennaro,Ciliberto ^[2] ; Paolo,De Paoli ^[3] ; Giovanni,Apolone ^[4] ; Maria Luisa,Lavitrano ^[5] ; Marco A,Pierotti ^[6] ; Giorgio,Stanta ^[7] ; On the behalf of the “dynamic medicine OECI group”

作者单位： Medical Oncology Unit and Scientific Directorate, Cancer Institute "Giovanni Paolo II", Viale Orazio Flacco, 65, 70124, Bari, Italy. n.silvestris@oncologico.bari.it. ^[1] Scientific Directorate, IRCCS National Cancer Institute "Regina Elena", Rome, Italy. ^[2] Scientific Directorate, IRCCS "Centro di Riferimento Oncologico", Aviano, Italy. ^[3] Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. ^[4] BBMRI.it and Department of Medicine and Surgery University Milano-Bicocca, Milan, Italy. ^[5] Senior Group Leader Foundation Institute FIRC Molecular Oncology (IFOM) Milan, Milan, Italy. ^[6] Department of Medical Sciences of the University of Trieste, Trieste, Italy. ^[7]

关键词 Clinical trials Dynamic Fluid N-of-1 trials Personalized medicine Target therapy

主题词临床试验(主题)(Clinical Trials as Topic);基因组学(Genomics);人类(Humans);医学肿瘤学(Medical Oncology);突变(Mutation);肿瘤(Neoplasms)

DOI 10.1186/s13046-017-0598-x

PMID 28903768

发布时间 2022-03-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交